BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37414322)

  • 1. Targeted miR-34a delivery with PD1 displayed bacterial outer membrane vesicles-coated zeolitic imidazolate framework nanoparticles for enhanced tumor therapy.
    Cui C; He Q; Wang J; Kang J; Ma W; Nian Y; Sun Z; Weng H
    Int J Biol Macromol; 2023 Aug; 247():125692. PubMed ID: 37414322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
    Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
    Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new era in cancer treatment: harnessing ZIF-8 nanoparticles for PD-1 inhibitor delivery.
    Rastin F; Oryani MA; Iranpour S; Javid H; Hashemzadeh A; Karimi-Shahri M
    J Mater Chem B; 2024 Jan; 12(4):872-894. PubMed ID: 38193564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
    Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-Scaled Zeolitic Imidazole Framework-8 as an Efficient Carrier for the Intracellular Delivery of RNase A in Cancer Treatment.
    Jia J; Zhang S; Wen K; Li Q
    Int J Nanomedicine; 2019; 14():9971-9981. PubMed ID: 31908453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteria-derived outer membrane vesicles engineered with over-expressed pre-miRNA as delivery nanocarriers for cancer therapy.
    Cui C; Guo T; Zhang S; Yang M; Cheng J; Wang J; Kang J; Ma W; Nian Y; Sun Z; Weng H
    Nanomedicine; 2022 Sep; 45():102585. PubMed ID: 35901958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy
    Li Y; Zhao R; Cheng K; Zhang K; Wang Y; Zhang Y; Li Y; Liu G; Xu J; Xu J; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
    ACS Nano; 2020 Dec; 14(12):16698-16711. PubMed ID: 33232124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance.
    Xu M; Hu Y; Ding W; Li F; Lin J; Wu M; Wu J; Wen LP; Qiu B; Wei PF; Li P
    Biomaterials; 2020 Nov; 258():120308. PubMed ID: 32841911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints.
    Wang Y; Zhang D; Jia M; Zheng X; Liu Y; Wang C; Lei F; Niu H; Li C
    J Drug Target; 2022 Nov; 30(9):1006-1016. PubMed ID: 35549591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells.
    Pan QS; Chen TT; Nie CP; Yi JT; Liu C; Hu YL; Chu X
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33070-33077. PubMed ID: 30203954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin doped zeolitic imidazolate framework nanoplatforms as multifunctional nanocarriers for tumor chemo/immunotherapy.
    Liu J; Liu S; Wu Y; Xu X; Li Q; Yang M; Gong A; Zhang M; Lu R; Du F
    Biomater Sci; 2022 May; 10(9):2384-2393. PubMed ID: 35383811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hollow Mesoporous Silica@Zeolitic Imidazolate Framework Capsules and Their Applications for Gentamicin Delivery.
    Xu X; Chen H; Wu X; Chen S; Qi J; He Z; Zou S; Xie L; Xu K; Yuan H; Sun Y; Zheng H; Kong W
    Neural Plast; 2018; 2018():2160854. PubMed ID: 29849553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
    Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
    Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides.
    Zhang H; Chen W; Gong K; Chen J
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.
    Liu Y; He M; Yuan Y; Nie C; Wei K; Zhang T; Chen T; Chu X
    ACS Nano; 2023 Apr; 17(8):7721-7732. PubMed ID: 37023215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
    Han TY; Hou LS; Li JX; Huan ML; Zhou SY; Zhang BL
    Int J Pharm; 2023 Mar; 635():122755. PubMed ID: 36801480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
    Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.